Research & Development

青青草AV在线视频观免久久这里只有精品视频6久久视频这里只精品马来西亚健身女神 颜值高身材好还会弹钢琴

發布時間︰

  “他存心不良!”   這讓彭氏非常的失望……青青草AV在线视频观免   當年太祖高皇帝與項羽決戰,兩軍疲憊,太祖高皇帝預備與項羽罷兵言和。久久这里只有精品视频6   說完了,就瞅著長長的甬道對雲瑯道︰“娶了當利之後,我就收心,你沒發覺我最近很老實嗎?”   雲瑯長嘆一聲,他知道在亂軍中落馬是個什麼下場,當成千上萬的騎兵開始沖鋒混戰的時候,馬蹄到處萬物皆為齏粉。久久视频这里只精品   現如今,在祁連山下與霍去病打了最後一仗的渾邪王上表求降!

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.


Connect? Registries


The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo